Name:
Myrophine
Type:
Opioid
AKA:
N/A
Myrophine image
Synthetic substance, no natural derivative
IUPAC Logo
Myrophine image
Myrophine, an opioid analgesic, was developed in the mid-20th century. It was used for pain management but has been largely replaced by more effective and safer opioids. It remains a historical example of early opioid research.
Synthetic Substances Image
Myrophine is an opioid analgesic with strong pain-relieving effects. It causes sedation, respiratory depression, and constricted pupils. Short-term use provides effective pain relief, while long-term use may lead to addiction and severe health issues. Overdose risks include severe respiratory depression and potential death. Safe use requires careful dosing and medical supervision. Recent research highlights its potency and associated risks with opioid use.
N/A
Myrophine, an opioid, interacts with mu-opioid receptors, leading to euphoria, relaxation, and pain relief. The effects are immediate, typically lasting a few hours. Long-term use can result in tolerance, dependence, and addiction. Psychological impacts include mood enhancement and sedation, but long-term use can lead to cognitive impairments, mood swings, and anxiety. Recent studies indicate potential risks for psychological dependence and cognitive decline due to chronic opioid use.
N/A
Myrophine is a synthetic opioid with analgesic properties. Its cultural significance is associated with pain management and the broader context of opioid use in medicine. Media coverage often highlights the opioid crisis and the challenges of managing potent opioids like myrophine. The substance is used medicinally, though its association with opioid dependence and abuse brings it into discussions about drug policy and addiction treatment.
N/A